Document Detail


Chronic congestive heart failure. Where have we been? Where are we heading?
MedLine Citation:
PMID:  3946465     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Chronic congestive heart failure is a frequently occurring disease associated with an impaired quality of life and significant mortality rate. Progress has been made in dissecting the pathophysiologic changes of congestive failure and in using vasodilators, newer positive inotropic agents, and other treatment modalities. Despite these advances, the overall mortality rate from congestive heart failure has not decreased. Further, many unanswered questions remain: How and why does a myocardial cell die? How should quality of life be measured? When should vasodilators and positive inotropic agents be given? What role do receptors play in pathogenesis and therapy? Can sudden death in heart failure be prevented? These and other questions will provide the stimulus for further studies in congestive heart failure.
Authors:
M M Applefeld
Related Documents :
6412535 - Hemodynamic effects of encainide in patients with ventricular arrhythmia and poor ventr...
17957325 - A clinical study of pattern and factors affecting outcome in nigerian patients with adv...
3094955 - Transcatheter treatment of myelomatous av shunting causing high-output failure.
2818455 - The use of levodopa, an oral dopamine precursor, in congestive heart failure.
9725415 - Management of recurrent ventricular tachycardia with ventricular assist device placement.
17614935 - Regulation and role of the presynaptic and myocardial na+/h+ exchanger nhe1: effects on...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of medicine     Volume:  80     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1986 Feb 
Date Detail:
Created Date:  1986-03-26     Completed Date:  1986-03-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  73-7     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aminopyridines / administration & dosage
Amrinone
Biopsy
Calcium Channel Blockers / therapeutic use
Cardiology / trends*
Chronic Disease
Digitalis
Dobutamine / administration & dosage
Dopamine / administration & dosage
Forecasting
Heart Failure / drug therapy,  mortality*,  pathology
Hemodynamics / drug effects
Humans
Infusions, Parenteral
Myocardial Contraction / drug effects
Myocardium / pathology
Plants, Medicinal
Plants, Toxic
Prognosis
Quality of Life
Vasodilator Agents / therapeutic use
Chemical
Reg. No./Substance:
0/Aminopyridines; 0/Calcium Channel Blockers; 0/Vasodilator Agents; 34368-04-2/Dobutamine; 60719-84-8/Amrinone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epidemiologic patterns, clinical evaluation, and long-term prognosis in chronic congestive heart fai...
Next Document:  Primary hyperparathyroidism presenting as cervical myelopathy.